No abstract available
Keywords:
Editorials; PCSK9 inhibitors; atherosclerosis; cholesterol, LDL; primary prevention; secondary prevention.
MeSH terms
-
Anticholesteremic Agents* / therapeutic use
-
Cholesterol, LDL
-
Humans
-
PCSK9 Inhibitors*
-
Proprotein Convertase 9
Substances
-
Anticholesteremic Agents
-
Cholesterol, LDL
-
PCSK9 Inhibitors
-
Proprotein Convertase 9